Wang H - Search Results

1

Proper definitions of MRI contrast enhancement in liver tumors.

Ni Y, Chen F, Wang H, Feng Y, Li J, Jiang Y. Ni Y, et al. Among authors: wang h. J Gastroenterol. 2010 Mar;45(3):349-50; author reply 351-2. doi: 10.1007/s00535-009-0174-z. Epub 2009 Dec 15. J Gastroenterol. 2010. PMID: 20012916 No abstract available.

2

Comparison between nonspecific and necrosis-avid gadolinium contrast agents in vascular disrupting agent-induced necrosis of rodent tumors at 3.0T.

Wang H, Miranda Cona M, Chen F, Li J, Yu J, Feng Y, Peeters R, De Keyzer F, Marchal G, Ni Y. Wang H, et al. Invest Radiol. 2011 Sep;46(9):531-8. doi: 10.1097/RLI.0b013e31821a2116. Invest Radiol. 2011. PMID: 21577133

3

Diffusion-weighted MRI of hepatic tumor in rats: comparison between in vivo and postmortem imaging acquisitions.

Sun X, Wang H, Chen F, De Keyzer F, Yu J, Jiang Y, Feng Y, Li J, Marchal G, Ni Y. Sun X, et al. Among authors: wang h. J Magn Reson Imaging. 2009 Mar;29(3):621-8. doi: 10.1002/jmri.21675. J Magn Reson Imaging. 2009. PMID: 19243058

4

Murine liver implantation of radiation-induced fibrosarcoma: characterization with MR imaging, microangiography and histopathology.

Wang H, Van de Putte M, Chen F, De Keyzer F, Jin L, Yu J, Marchal G, de Witte P, Ni Y. Wang H, et al. Eur Radiol. 2008 Jul;18(7):1422-30. doi: 10.1007/s00330-008-0904-2. Epub 2008 Mar 15. Eur Radiol. 2008. PMID: 18343928

5

A modified rabbit model of reperfused myocardial infarction for cardiac MR imaging research.

Feng Y, Xie Y, Wang H, Chen F, Ye Y, Jin L, Marchal G, Ni Y. Feng Y, et al. Among authors: wang h. Int J Cardiovasc Imaging. 2009 Mar;25(3):289-98. doi: 10.1007/s10554-008-9393-2. Epub 2008 Dec 2. Int J Cardiovasc Imaging. 2009. PMID: 19043805

6

Tumor models and specific contrast agents for small animal imaging in oncology.

Ni Y, Wang H, Chen F, Li J, DeKeyzer F, Feng Y, Yu J, Bosmans H, Marchal G. Ni Y, et al. Among authors: wang h. Methods. 2009 Jun;48(2):125-38. doi: 10.1016/j.ymeth.2009.03.014. Epub 2009 Mar 26. Methods. 2009. PMID: 19328231 Free article.

7

Comparison of two vascular-disrupting agents at a clinically relevant dose in rodent liver tumors with multiparametric magnetic resonance imaging biomarkers.

Wang H, Cona MM, Chen F, Yu J, Feng Y, Li J, Keyzer FD, Marchal G, Ni Y. Wang H, et al. Anticancer Drugs. 2012 Jan;23(1):12-21. doi: 10.1097/CAD.0b013e328349dd60. Anticancer Drugs. 2012. PMID: 21857503

8

Study on the microbial safety of an infusion set for contrast-enhanced imaging.

Cona MM, Bauwens M, Zheng Y, Coudyzer W, Li J, Feng Y, Wang H, Chen F, Verbruggen A, Oyen R, Ni Y. Cona MM, et al. Among authors: wang h. Invest Radiol. 2012 Apr;47(4):247-51. doi: 10.1097/RLI.0b013e31823c0f87. Invest Radiol. 2012. PMID: 22353856

9

Enhanced antitumor efficacy of a vascular disrupting agent combined with an antiangiogenic in a rat liver tumor model evaluated by multiparametric MRI.

Chen F, Feng Y, Zheng K, De Keyzer F, Li J, Feng Y, Cona MM, Wang H, Jiang Y, Yu J, Marchal G, Verfaillie C, De Geest B, Oyen R, Ni Y. Chen F, et al. Among authors: wang h. PLoS One. 2012;7(7):e41140. doi: 10.1371/journal.pone.0041140. Epub 2012 Jul 18. PLoS One. 2012. PMID: 22815943 Free PMC article.

10

Continuing pursuit for ideal systemic anticancer radiotherapeutics.

Cona MM, Wang H, Li J, Feng Y, Chen F, de Witte P, Verbruggen A, Ni Y. Cona MM, et al. Among authors: wang h. Invest New Drugs. 2012 Oct;30(5):2050-65. doi: 10.1007/s10637-011-9758-6. Epub 2011 Oct 18. Invest New Drugs. 2012. PMID: 22006160 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152,062 results

Search Page

Filters